A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
FONAR Corporation, sometimes referred to as the “Company” or “FONAR”, is a Delaware corporation which was incorporated on July 17, 1978. Our address is 110 Marcus Drive, Melville, New York 11747 and our telephone number is 631-694-2929. FONAR also maintains a website at www.fonar.com. FONAR provides copies of its filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and amendments to these reports to stockholders on request. We conduct our business in two segments. Our medical equipment segment is conducted directly through FONAR. Our physician management and diagnostic services segment is conducted through our subsidiary Health Management Corporation of America (“HMCA”).
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 106M | 104M | 103M | 99M | 98M | 90M |
| Net Income | 7.6M | 8.3M | 11M | 9.4M | 12M | 9.6M |
| EPS | $1.15 | $1.23 | $1.53 | $1.32 | $1.75 | $1.45 |
| Free Cash Flow | 5.7M | 7.5M | 13M | 10M | 11M | 16M |
| ROIC | 0.0% | 7.8% | - | 8.0% | - | 6.9% |
| Gross Margin | 81.3% | 45.6% | 48.4% | 51.0% | 53.2% | 53.2% |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 0 | 11M | - | 11M | - | -7.1M |
| Operating Margin | 0.0% | 11.0% | - | 11.3% | - | -7.9% |
| ROE | 4.3% | 4.9% | 6.4% | 5.9% | 8.3% | 6.9% |
| Shares Outstanding | 6,173M | 7M | 7M | 7M | 7M | 7M |
FONAR CORP passes 2 of 9 quality checks, indicating weak fundamentals.
FONAR CORP trades at 16.3x trailing earnings, compared to its 15-year median P/E of 9.9x, suggesting it is currently Expensive relative to its historical range. The company's 5-year average ROIC is 7.6% with a gross margin of 50.3%. At current prices, the estimated annualized return to fair value is -28.4%.
FONAR CORP (FONR) has a current P/E ratio of 16.3, compared to its historical median P/E of 9.9. The stock is currently considered Expensive based on its historical valuation range.
FONAR CORP (FONR) has a 5-year average return on invested capital (ROIC) of 7.6%. This is below average and may indicate limited pricing power.
FONAR CORP (FONR) has a market capitalization of $115.5B. It is classified as a large-cap stock.
FONAR CORP (FONR) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.00%.
Based on historical P/E analysis, FONAR CORP (FONR) appears expensive. The current P/E of 16.3 is 64% above its historical median of 9.9. The estimated fair value CAGR (P/E method) is -1.3%.
FONAR CORP (FONR) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
FONAR CORP (FONR) reported annual revenue of $104 million in its most recent fiscal year, based on SEC EDGAR filings.
FONAR CORP (FONR) has a net profit margin of 8.0%. This is a modest margin.
FONAR CORP (FONR) generated $7 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
FONAR CORP (FONR) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
FONAR CORP (FONR) reported earnings per share (EPS) of $1.23 in its most recent fiscal year.
FONAR CORP (FONR) has a return on equity (ROE) of 4.9%. This indicates moderate shareholder returns.
FONAR CORP (FONR) has a 5-year average gross margin of 50.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for FONAR CORP (FONR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
FONAR CORP (FONR) has a book value per share of $25.47, based on its most recent annual SEC filing.